Conflicted psychiatrist leaves Emory

The Emory University psychiatry researcher who failed to report hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in funding from the National Institutes of Health to study the company's anti-depressant drugs is leaving the university, according to the linkurl:__Atlanta Journal-Constitution__.;http://www.ajc.com/health/controversial-emory-researcher-leaving-179261.html?cxtype=rss_news_128746 linkurl:Charles Nemeroff,;http://www.psychiatry.emo

By | November 2, 2009

The Emory University psychiatry researcher who failed to report hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in funding from the National Institutes of Health to study the company's anti-depressant drugs is leaving the university, according to the linkurl:__Atlanta Journal-Constitution__.;http://www.ajc.com/health/controversial-emory-researcher-leaving-179261.html?cxtype=rss_news_128746 linkurl:Charles Nemeroff,;http://www.psychiatry.emory.edu/NeuropsychopharmacologyLaboratory/Charles%20Nemeroff.htm# a renowned depression researcher, failed to disclose to Emory approximately $800,000 in payments he received from drug maker GlaxoSmithKline (GSK) while he was the principal investigator (PI) on a multi-million dollar grant from the NIH to study five GSK antidepressants. Amid an investigation conducted by Emory, Nemeroff stepped down from his position as chairman of the psychiatry department last October. Later that month, the psychiatrist stepped down as PI from the $9.3 million NIH grant as the Senate probed his failure to disclose income from GSK, and the NIH froze funding on the five-year grant. Emory officials told the __Atlanta Journal-Constitution__ that Nemeroff had not officially submitted his resignation as of last Friday (30th October), but that they were contacted by the institution that is hiring Nemeroff. They did not disclose what institution that was, but said that the university would issue an official announcement regarding Nemeroff's departure sometime today (2nd November). Ed Silverman over at the __Pharmalot__ blog linkurl:reported;http://www.pharmalot.com/2009/10/amid-inquiries-nemeroff-looks-beyond-emory/ last week that the University of Miami's Miller School of Medicine would be Nemeroff's new home, citing "sources familiar with the school."
**__Related stories:__***linkurl:NIH to act on conflicts within 1 year;https://www.the-scientist.com/blog/display/55264/
[5th December 2008]*linkurl:NIH $ frozen amid conflict probe;https://www.the-scientist.com/blog/display/55088/
[14th October 2008]*linkurl:Emory psychiatrist steps down;https://www.the-scientist.com/blog/display/55072/
[6th October 2008]

Comments

Avatar of: anonymous poster

anonymous poster

Posts: 77

November 2, 2009

Seems a bit of an mis- or understatement. Conflicted is a term better suited to a patient - or victim of a forced choice between two equal valued alternatives. \n\nCrooked would be more apropos for someone in the position of power whose choice is between clearly good and clearly bad (or, have good and bad also been lost the ever-widening sea of rationalizations against judgment of even the most blatant violations of basic social norms or mores)?
Avatar of: Cheryl Soehl

Cheryl Soehl

Posts: 15

November 2, 2009

What needs to be examined is the willingness of another institution to hire him in light of what is appears to be truly a complete moral and ethical lapse.\n\nPhysician heal thyself, and academe do the same!!!!!\n\nThe only thing that will stop moral decay is appropriate outrage and drawing a line in the sand to reject any and all justifications for supporting liars, cheats and miscreants. These are people's lives at stake, not some abstract scientific principle.\n\nShame! Shame!\n
Avatar of: anonymous poster

anonymous poster

Posts: 4

November 2, 2009

"... renowned depression researcher"? Really? Quick -- somebody tell us what are his original contributions to the field that have stood up to scrutiny. He appears more like a notorious operator and impresario. He has been called Boss of Bosses and also the Tom DeLay of psychiatry.
Avatar of: anonymous poster

anonymous poster

Posts: 15

November 2, 2009

While the CEO of my former ?Big Pharma? corporation was not doing his job nor was his henchman; no instead the FDA stepped in and slapped their wrists (fined the corporation), not once but twice. Finally the FDA got serious and the end result was the CEO left the company to sit on the board of directors for a major personal products conglomerate and the henchman left to sit on the board at a major news organization on the east coast. Me, on the other hand, watched my career dissolve over the next two years partially due to the across the boards work force reduction in that company as a result of this. Worst part is that my division was not involved in the misbehavior and now I have been out of work for nearly 6 years.
Avatar of: anonymous poster

anonymous poster

Posts: 18

November 2, 2009

Contrary to some statements about Dr. Nemeroff, he is both intelligent and competent, and has made legitimate and untarnished contributions. That said, somewhere he has lost the good judgement or common sense that are necessary for leadership (and worse, appears not to understand the inherent issues). His worst conflict of interest violations were not the pharma payments -- at least twice there have been high profile cases where he published and failed to declare what any responsible person knew were CoIs. Shame on the University of Miami. It sounds like their former football recruiting ethos has worked its way upstairs.
Avatar of: anonymous poster

anonymous poster

Posts: 1

November 2, 2009

He will be successful at the University of Miami (UM). This is the kind of guy UM is looking for.
Avatar of: Renton Innes

Renton Innes

Posts: 7

November 4, 2009

I mean, everyone who has gone through a tough time or traumatic experience, or works hard to impress and ensure income with their field of expertise, things can get on top of you. we all have our high and low points of our exsistance, when compared to others expectations and roles, to impress each other. hmmm. luck ? or bad decisions ?! who's laughing now.

Popular Now

  1. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  2. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS